An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Elanco Adds Animal Health Veteran to Executive Committee
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary
Elanco Animal Health (NYSE: ELAN) announced the appointment of Tim Bettington as the executive vice president of Corporate Strategy and Market Development, effective March 20. Bettington's role will focus on corporate strategy and market development, particularly in preparing for a significant innovation period and driving growth initiatives for 2025 and beyond. He brings over 25 years of experience in animal health, previously serving at Zoetis and Boehringer Ingelheim. CEO Jeff Simmons emphasized the addition strengthens Elanco's leadership, aimed at enhancing market share and executing successful product launches amidst an exciting pipeline.
Positive
Appointment of a seasoned leader, Tim Bettington, to enhance corporate strategy and market development.
Bettington's expertise expected to drive growth and innovation initiatives for 2025 and beyond.
CEO Jeff Simmons indicates strong confidence in the company’s leadership and innovation pipeline.
Negative
None.
Tim Bettington joins Elanco as EVP Corporate Strategy and Market Development
GREENFIELD, Ind.--(BUSINESS WIRE)--
Elanco Animal Health (NYSE: ELAN) announced today the appointment of Tim Bettington as the company’s executive vice president Corporate Strategy and Market Development. He will join Elanco’s executive committee on March 20.
As Elanco shifts from the separation and stand up of the independent company and the integration of the Bayer Animal Health acquisition to an increasing focus on delivering its next era of innovation and growth, Bettington’s expertise complements the company’s existing commercial leadership team. In his role, Bettington will be responsible for corporate strategy and market development, focused on launch readiness and preparing Elanco for a historic innovation window, while also driving growth initiatives for 2025 and beyond.
“At Elanco, we have continued to build a team and capabilities to fuel what I believe is one of the most exciting long-term value propositions in the industry. Our commercial leadership team is positioned to drive execution, grow market share and launch with excellence as we enter Elanco’s next era of innovation,” says Jeff Simmons, president and CEO at Elanco. “Adding Tim to the team with his expertise launching some of the most successful blockbusters in our industry and building next level customer demand generation capabilities is a direct signal of the progress and potential of our pipeline. Launching this historic window of innovation with excellence is our top priority and he will be a great addition to our existing lead team as we further our commercial excellence efforts.”
Bettington is a recognized animal health leader with more than 25 years of experience across both livestock and pet health, beginning in his native country Australia, the U.S. and across Europe. Tim has built some of the industry’s most successful portfolios and overseen some of the most significant commercial businesses in animal health. Bettington most recently served as executive vice president and president, U.S. Operations and Global Customer Experience at Zoetis where he led the company’s rapid pet health growth and drove expansive market penetration for new innovation. Prior to Zoetis, he served as North American Region Head of Commercial Operations for Boehringer Ingelheim’s animal health business. In that role, Bettington had oversight for the Pet Veterinary, Pet OTC, Cattle, Swine, Equine and Poultry businesses. In roles at Zoetis, Boehringer Ingelheim and Novartis Animal Health, Bettington developed deep expertise in sales excellence, product launch, strategy and business integration.
“As I considered the next step in my career journey, Elanco was the obvious choice. Elanco has long been known for its special, purpose-driven culture and drive to advocate on customer’s greatest challenges – creating some of the strongest customer relationships in the industry,” Bettington said. “When you combine that with the strength of Elanco’s pipeline, I believe they’re also now the company with the greatest potential for long-term value creation. I’m excited about the way my experience can help Elanco achieve this success.”
Bettington holds a bachelor's degree in Agriculture from Western Sydney University and a master's degree in Marketing Management from the Macquarie Graduate School of Management in Sydney.
ABOUT ELANCO
Elanco Animal Health Incorporated (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders, and society as a whole. With nearly 70 years of animal health heritage, we are committed to helping our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we are driven by our vision of Food and Companionship Enriching Life and our Elanco Healthy Purpose™ Sustainability Pledges –all to advance the health of animals, people, and the planet. Learn more at elanco.com.
Tim Bettington is the newly appointed executive vice president of Corporate Strategy and Market Development at Elanco Animal Health, effective March 20.
What is Tim Bettington's role at Elanco?
Tim Bettington will focus on corporate strategy and market development, preparing Elanco for innovation and growth initiatives for 2025.
What experience does Tim Bettington bring to Elanco?
Tim Bettington has over 25 years of experience in animal health, previously serving in leadership roles at Zoetis and Boehringer Ingelheim.
What does the appointment of Tim Bettington mean for Elanco's future?
Bettington's appointment is expected to strengthen Elanco's leadership and enhance its market share and product launch capabilities.
